Shareholders’ Equity and Equity Compensation - Schedule of Share-Based Payment Arrangement, Option, Activity (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 03, 2025	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Number of Options
Beginning balance (in shares)				21,770,225
Granted (in shares)	1,530,000			3,085,295
Exercised (in shares)				(686,254)
Cancelled/forfeited (in shares)				(665,134)
Expired (in shares)				(156)
Ending balance (in shares)		23,503,976		23,503,976		21,770,225
Total exercisable (in share)		17,018,261		17,018,261
Total vested or expected to vest (in shares)		22,478,922		22,478,922
Weighted Average Exercise Price Per Share
Beginning balance (in dollars per share)				$ 9.06
Granted (in dollars per share)	$ 18.60			18.79
Exercised (in dollars per share)				6.14
Cancelled/forfeited (in dollars per share)				12.56
Expired (in dollars per share)				2.44
Ending balance (in dollars per share)		$ 10.33		10.33		$ 9.06
Total exercisable (in dollars per share)		7.53		7.53
Total vested or expected to vest (in dollars per share)		$ 9.99		$ 9.99
Weighted Average Remaining Contract Term
Total outstanding as of December 31, 2024:				5 years 6 months 18 days		5 years 4 months 24 days
Total outstanding as of June 30, 2025				5 years 6 months 18 days		5 years 4 months 24 days
Total exercisable as of June 30, 2025				4 years 4 months 13 days
Total vested or expected to vest as of June 30, 2025				5 years 4 months 28 days
Aggregate Intrinsic Value
Total outstanding as of December 31, 2024:				$ 226,117
Granted				1,040
Exercised		$ 10,800	$ 1,100	12,613	$ 1,500
Cancelled/forfeited				6,292
Expired				4
Total outstanding as of June 30, 2025		348,605		348,605		$ 226,117
Total exercisable as of June 30, 2025		299,962		299,962
Total vested or expected to vest as of June 30, 2025		$ 341,097		$ 341,097